NFKB1 and Hepatic fibrosis: GAMG exhibited stronger anticancer action through down-regulating the expression of protein p65 [5], improved CCl4-induced hepatic fibrosis by suppressing NF-κB and MAPK signaling pathway [6], and alleviated single-walled carbon nanotubes-induced lung inflammation and fibrosis in mice by the PI3K/AKT/NF-κB signaling pathway [7].